Potential side effects of microdermabrasion are minimal and this is a very safe procedure. Potential drawbacks are very limited in that microderm only affects the epidermis, which is the outermost skin layer. Common minor, temporary side effects include slight skin tightness, redness, bruising, and sensitivity. As a general rule, the greater the potential benefits with a cosmetic treatment, the greater the potential risks and side effects. The possible risks with more aggressive treatments like dermabrasion and laser are much greater than microdermabrasion.
Possible side effects of microdermabrasion include
- skin tightness,
- redness,
- minor bruising,
- skin sensitivity,
- post-inflammatory hyperpigmentation (PIH),
- small skin abrasions,
- spots of bleeding,
- eye-skin bruising (especially if you are taking aspirinor other blood thinners),
- fine broken blood vessels (telangiectasia),
- and cold sore reactivation around lips.
COLD SORES
Cold sore reactivation may uncommonly occur after microderm around lips. If you have had a lot of previous cold sores, consider either avoiding treatment around the lip borders or asking your doctor about taking an antiviral pill prophylactically.
INFLAMMATION
Overly aggressive microderm may cause breaks in skin and resulting post-inflammatory hyperpigmentation (PIH). Also overaggressive treatment may cause an increased risk of bruising (ecchymosis), especially if you are taking aspirin or other blood thinners like warfarin (Coumadin) or clopidogrel bisulfate (Plavix). Since microdermabrasion only causes superficial skin removal, scarring and pigment changes are very rare if the procedure is performed correctly.
MEDICATIONS
In addition, if an individual is on isotretinoin (Accutane) or has taken this medication within the previous six to 12 months, resurfacing treatments such as microdermabrasion may not be appropriate due to the potential increased risk of scarring. As the potential risk is very slight, some dermatologists may treat patients on isotretonion with gentler sessions.